Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ocean Biomediacal Inc (OCEA)

Ocean Biomediacal Inc (OCEA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Ocean Biomedical Expands into Energy and Digital Asset Sectors to Accelerate Growth and Shareholder Value

OCEA : 0.0007 (+133.33%)
Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China

OCEA : 0.0007 (+133.33%)
Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development

OCEA : 0.0007 (+133.33%)
Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway

OCEA : 0.0007 (+133.33%)
Ocean Biomedical, Inc. Faces Compliance Issues with Nasdaq Due to Delayed Financial Filings

Ocean Biomedical received a Nasdaq compliance notice for delayed financial report filings, impacting potential listing status.Quiver AI SummaryOcean Biomedical, Inc. announced it received a notice from...

OCEA : 0.0007 (+133.33%)
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

OCEA : 0.0007 (+133.33%)
Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter

OCEA : 0.0007 (+133.33%)
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:OCEA),(NASDAQ:LVTX),(NYSE:MRK),(NYSE:ABBV) EQNX::TICKER_END

ONCY : 1.0250 (+0.49%)
OCEA : 0.0007 (+133.33%)
MRK : 116.35 (-0.63%)
ABBV : 228.80 (+0.79%)
ONC.TO : 1.42 (+2.16%)
LVTX : 1.7400 (-3.87%)
The Global Metastatic Breast Cancer Treatment Market Expected To Reach $31 Billion By 2028

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:PFE),(NASDAQ:OCEA),(NYSE:NVS),(NASDAQ:RLAY) EQNX::TICKER_END

ONCY : 1.0250 (+0.49%)
OCEA : 0.0007 (+133.33%)
RLAY : 10.84 (+1.40%)
NVS : 155.97 (-1.59%)
ONC.TO : 1.42 (+2.16%)
PFE : 27.13 (-0.11%)
The Global Metastatic Breast Cancer Treatment Market Expected To Reach $31 Billion By 2028

/PRNewswire/ -- Metastatic breast cancer is the advanced stage of breast cancer, including cases wherein cancer has spread to the other parts of the body from...

ONCY : 1.0250 (+0.49%)
OCEA : 0.0007 (+133.33%)
RLAY : 10.84 (+1.40%)
NVS : 155.97 (-1.59%)
ONC.TO : 1.42 (+2.16%)
PFE : 27.13 (-0.11%)

Barchart Exclusives

Consumer Staples Don’t Have to Be Boring. This Giant’s Up 70% and Counting.
Coca-Cola Consolidated (COKE) is trading at a new all-time high and has strong technical momentum. Shares are up nearly 70% over the past 52 weeks. COKE currently maintains a 100% “Buy” technical opinion from Barchart. Analyst sentiment is mixed with price targets ranging from $160 to $342. Today’s Featured Stock... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar